Brensocatib (Brinsupri) first FDA-approved targeted therapy for non-cystic fibrosis bronchiectasis
Ann Med Surg (Lond)
.
2025 Dec 16;88(2):1184-1186.
doi: 10.1097/MS9.0000000000004614.
eCollection 2026 Feb.
Authors
Zuha Babar
1
,
Muhammad Hamza Khan
1
,
Maheen Rehman
1
,
Raghabendra Kumar Mahato
2
Affiliations
1
Department of Medicine, Ayub Medical College, Abbottabad, Pakistan.
2
Department of Medicine, Gandaki Medical College Teaching Hospital and Research Center, Pokhara, Nepal.
PMID:
41675736
PMCID:
PMC12889407
DOI:
10.1097/MS9.0000000000004614
No abstract available
Publication types
Editorial